MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Establishment Labs Holdings Operating Expenses 2011-2026 | ESTA
Annual Operating Expenses Establishment Labs Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 M | 172 M | 146 M | 111 M | 80.4 M | 85.8 M | 60 M | 37.7 M | 25.9 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 172 M | 25.9 M | 97.6 M |
Quarterly Operating Expenses Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.7 M | 49.4 M | 44.8 M | - | 38.9 M | 38.3 M | 33.2 M | - | 47.1 M | 44 M | 38.2 M | - | 36.6 M | 37.9 M | 30.5 M | - | 28.7 M | 26.1 M | 22.2 M | - | 17.7 M | 16.8 M | 23.2 M | - | 23 M | 22.4 M | 19.6 M | - | 16.2 M | 14.5 M | 10.8 M | - | 9.58 M | 9.61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49.4 M | 9.58 M | 28.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
456 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
AxoGen
AXGN
|
121 M | $ 31.85 | 2.68 % | $ 1.41 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 8.97 | -1.59 % | $ 644 M |  Israel |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.89 | -2.51 % | $ 135 M | USA |
 |
Alphatec Holdings
ATEC
|
560 M | $ 16.95 | -4.48 % | $ 2.42 B | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 312.8 | -0.23 % | $ 8.83 B | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 41.19 | -0.91 % | $ 1.27 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.69 | -9.12 % | $ 138 M |  France |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 50.26 | 3.85 % | $ 7.49 K | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 91.09 | 3.43 % | $ 134 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 121.01 | -0.61 % | $ 211 B | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.79 | -1.11 % | $ 1.09 B | Israel |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 27.84 | 0.04 % | $ 235 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 165.75 | -3.35 % | $ 12.4 B | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.81 | -3.78 % | $ 83.2 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.82 | -5.67 % | $ 374 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.68 | 0.24 % | $ 122 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 102.68 | 0.67 % | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
251 M | $ 84.87 | -1.06 % | $ 2.85 B | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 62.45 | 0.55 % | $ 3.39 B |  Britain |
 |
Globus Medical
GMED
|
547 M | $ 92.68 | -0.85 % | $ 12.6 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 11.98 | -3.51 % | $ 923 M | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
120 M | $ 1.78 | 0.28 % | $ 69.6 M | USA |